» Articles » PMID: 26819710

Interleukin 20 Regulates Dendritic Cell Migration and Expression of Co-stimulatory Molecules

Overview
Journal Mol Cell Ther
Specialty Biochemistry
Date 2016 Jan 29
PMID 26819710
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psoriasis is an inflammatory disease characterized by leukocyte skin infiltration. Interestingly, recent works suggest that the migration of dendritic cells (DCs) is abnormal in psoriatic skin. DCs have significant role in regulating the function of T lymphocytes, at least in part influenced by the local environment of cytokines. In psoriatic skin lesions the expression of IL-20 is highly up-regulated. It is unclear if this cytokine has any influence on DCs.

Methods: Here, we investigated the influence of IL-20 in monocyte-derived dendritic cell (MDDCs) in vitro. This work addressed IL-20 effects on DC maturation, receptor expression and signaling. By use of extra cellular matrix components mimicking the skin environment, we also studied the functional effects of IL-20 on the chemotactic migration of DCs. Based on the recent finding that CD18 integrin are shed during migration of myeloid leukocytes, the concentration of these adhesion molecules was measured in MDDCs culture supernatants post migration.

Results: Following stimulation with IL-20, immature human MDDCs enhanced the expression of the co-stimulatory molecule CD86, further enabling activation of the p38 MAPK, but not the STAT3, pathway. IL-20 increased the migration of MDDCs in a biphasic response narrowly controlled by the interleukin concentration. A concomitant change in the shedding of CD18 integrins suggested that these adhesion molecules play a role in the migration of the MDDCs through the extracellular matrix layer.

Conclusion: Taken together, our findings points to a possible, yet subtle, role of IL-20 in DCs migration. The biphasic response suggests that the aberrant IL-20 expression in psoriasis impedes DC migration, which could be a part of the processes that precipitates the dysregulated inflammatory response associated with this disease.

Citing Articles

Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD.

Lee S, Choi Y, Kim D, Jeong H, Do Y, Jung S Transl Psychiatry. 2025; 15(1):28.

PMID: 39863599 PMC: 11762770. DOI: 10.1038/s41398-024-03201-6.


Causal relationship between circulating cytokines and follicular lymphoma: a two-sample Mendelian randomization study.

Sun C, Liu C, Liu X, Wu Z, Luo J, Liu R Am J Cancer Res. 2024; 14(4):1577-1593.

PMID: 38726270 PMC: 11076242. DOI: 10.62347/JCKD6973.


Interleukin 24: Signal Transduction Pathways.

Smith S, Lopez S, Kim A, Kasteri J, Olumuyide E, Punu K Cancers (Basel). 2023; 15(13).

PMID: 37444474 PMC: 10340555. DOI: 10.3390/cancers15133365.


IL-20 Activates ERK1/2 and Suppresses Splicing of X-Box Protein-1 in Intestinal Epithelial Cells but Does Not Improve Pathology in Acute or Chronic Models of Colitis.

Moniruzzaman M, Wong K, Wang R, Symon H, Mueller A, Rahman M Int J Mol Sci. 2023; 24(1).

PMID: 36613621 PMC: 9820550. DOI: 10.3390/ijms24010174.


Expression of IL-20 Receptor Subunit β Is Linked to EAE Neuropathology and CNS Neuroinflammation.

Dayton J, Yuan Y, Pacumio L, Dorflinger B, Yoo S, Olson M Front Cell Neurosci. 2021; 15:683687.

PMID: 34557075 PMC: 8452993. DOI: 10.3389/fncel.2021.683687.


References
1.
Zhang X, Zhan D, Shin H . Integrin subtype-dependent CD18 cleavage under shear and its influence on leukocyte-platelet binding. J Leukoc Biol. 2012; 93(2):251-8. DOI: 10.1189/jlb.0612302. View

2.
Talamonti M, Spallone G, Di Stefani A, Costanzo A, Chimenti S . Efalizumab. Expert Opin Drug Saf. 2011; 10(2):239-51. DOI: 10.1517/14740338.2011.524925. View

3.
BLUMBERG H, Conklin D, Xu W, Grossmann A, Brender T, Carollo S . Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell. 2001; 104(1):9-19. DOI: 10.1016/s0092-8674(01)00187-8. View

4.
Evans B, McDowall A, Taylor P, Hogg N, Haskard D, Landis R . Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response. Blood. 2006; 107(9):3593-9. DOI: 10.1182/blood-2005-09-3695. View

5.
Murray P . Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol. 2006; 6(4):379-86. DOI: 10.1016/j.coph.2006.01.010. View